New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

Aldeyra Therapeutics has disclosed positive results from the first of multiple Phase 3 studies of a new type of inflammation-fighting medicine the Lexington, MA, company has been testing in a variety of conditions.